A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

On Christmas Day, Elon Musk turned heads with a decadent photo by his tree. Dressed head-to-toe in a Santa costume, he ...

Exercise includes cardio and strength training, which together support heart health, healthy blood sugar levels, and weight ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.